Prudential Financial
INO icon

Prudential Financial’s Inovio Pharmaceuticals INO Stock Holding History

Prudential Financial’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,484
Closed -$14.6K – 2655
2023
Q1 		$14.6K Hold
1,484
– – ﹤0.01% 2573
2022
Q4 		$27.8K Buy
1,484
+14
+1% +$317 ﹤0.01% 2549
2022
Q3 		$30K Buy
1,470
+142
+11% +$3.63K ﹤0.01% 2601
2022
Q2 		$28K Hold
1,328
– – ﹤0.01% 2627
2022
Q1 		$57K Hold
1,328
– – ﹤0.01% 2566
2021
Q4 		$80K Sell
1,328
-83
-6% -$6.65K ﹤0.01% 2586
2021
Q3 		$121K Buy
1,411
+55
+4% +$5.52K ﹤0.01% 2517
2021
Q2 		$151K Buy
1,356
+177
+15% +$17K ﹤0.01% 2476
2021
Q1 		$131K Buy
1,179
+132
+13% +$17.4K ﹤0.01% 2435
2020
Q4 		$111K Buy
1,047
+21
+2% +$2.8K ﹤0.01% 2389
2020
Q3 		$143K Buy
1,026
+51
+5% +$10.6K ﹤0.01% 2335
2020
Q2 		$315K Buy
+975
New +$157K ﹤0.01% 2096
2014
Q3 		– Sell
-1,017
Closed -$132K – 2253
2014
Q2 		$132K Buy
1,017
+767
+307% +$90.5K ﹤0.01% 2316
2014
Q1 		$40K Hold
250
– – ﹤0.01% 2237
2013
Q4 		$35K Sell
250
-83
-25% -$8.31K ﹤0.01% 2265
2013
Q3 		$33K Sell
333
-73
-18% -$6.12K ﹤0.01% 2258
2013
Q2 		$16K Buy
+406
New +$12.3K ﹤0.01% 2287

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Prudential Financial's INO Position: Q2 2023 in Review

Prudential Financial sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 1,484 shares — an estimated $14.6K sold.

Prudential Financial first reported a position in INO in Q2 2013 and held it in 17 quarters. The position peaked at $315K in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Prudential Financial reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Prudential Financial sold 1,484 Inovio Pharmaceuticals shares in Q2 2023, an estimated $14.6K.
  • Prudential Financial first reported a position in Inovio Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Prudential Financial's Inovio Pharmaceuticals position peaked at $315K in Q2 2020.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Prudential Financial's 13F filing for Q2 2023, filed 11 Aug 2023.